WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH.

Ruth Klara Maria Kirschner-Hermanns Petra FunkNadine Leistner

Published in: Therapeutic advances in urology (2019)

The results suggest WS PRO 160 I 120 mg to be considered as a valid alternative in the treatment of patients with early BPH, especially with view to sexual function and a good quality of life, especially in long-term use.

Keyphrases

lower urinary tract symptoms
benign prostatic hyperplasia
anti inflammatory
oxidative stress
replacement therapy